RxDoctor Payments DataLook up a doctor →

Otezla: payments to doctors

Payments that named Otezla as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$50.6M
Providers
96,853
Transactions
787,134
Average per transaction
$64

The per-transaction average — $64 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 96,853 providers the average total is $523, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Amgen$41,163,35981.3%
Bristol Myers Squibb$9,467,65818.7%
E.r. Squibb & Sons, L.L.C.$2320.0%
← All drugs & devices